ArticleBioactive materials2025
Inherently bioactive iron-chelating Poly (N-acryloyl 2-glycine)/chitosan hydrogel scaffolds orchestrating dual hypoxic-immune microenvironment for functional meniscus regeneration.
Article in Bioactive materials, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Liquid-Responsive Shape-Memory Nanofiber-Reinforced Scaffolds for Cartilage Repair.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Article
- [Advances in immunomodulatory strategies for meniscal regeneration].Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery · 2026Review
- Materiobiology-guided regulation of mesenchymal stromal cell fate for aging-related diseases: From basic parameter design to clinical application.Bioactive materials · 2026Review
- Applications of Multifunctional Hydrogel in Tissue Engineering and Regenerative Medicine.MedComm · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Despite progress in tissue-engineered meniscus (TEM) as alternatives to meniscectomy, challenges remain in inflammatory regulation, oxidative resistance, and mechanical stability under pathological microenvironments. Innovatively, we combined personalized meniscus scaffold, hydrogel ion crosslinking network technology, and microenvironment regulation function to prepare a multifunctional poly (N-acryloyl 2-glycine)/chitosan (PACG/CS) composite hydrogel meniscus scaffold featuring heterogeneous bionic structure, high strength and toughness, hypoxic inducing activity, and anti-inflammatory and antioxidant effects. Crucially, the inherently bioactive hydrogel networks crucially leveraged their carboxyl groups to orchestrate iron ion chelation, establishing a hypoxia-mediated microenvironment that dynamically modulated pro-/anti-inflammatory equilibrium, which in turn supported the chondrocyte survival, facilitated the development of a cartilage matrix, and ultimately promoted the meniscus regeneration. Notably, peripheral blood mesenchymal stem cells (PBMSCs) exhibited superior meniscus regeneration efficiency in low-oxygen conditions compared to bone marrow mesenchymal stem cells (BMSCs). After evaluating the effects of hypoxia environment induced by highly efficient iron chelation of PACG/CS hydrogel scaffolds on the activation of HIF-1α signaling pathway, anti-inflammatory and antioxidant regulation, the regulatory mechanism of immune microenvironment on the growth and cultivation quality of TEM were elucidated
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.